ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,958,274 | -36.3% | 2,377,665 | -21.5% | 12.23% | -10.9% |
| Q2 2023 | $20,334,212 | -24.0% | 3,030,434 | 0.0% | 13.72% | -22.4% |
| Q1 2023 | $26,758,732 | +15.6% | 3,030,434 | 0.0% | 17.69% | +13.8% |
| Q4 2022 | $23,152,516 | -9.7% | 3,030,434 | -15.8% | 15.55% | +50.3% |
| Q3 2022 | $25,635,000 | +1.5% | 3,600,434 | +15.4% | 10.35% | -24.5% |
| Q2 2022 | $25,244,000 | +149.1% | 3,120,434 | +1139.8% | 13.71% | +176.9% |
| Q1 2021 | $10,133,000 | -58.8% | 251,695 | -39.5% | 4.95% | -32.5% |
| Q4 2020 | $24,609,000 | – | 416,200 | – | 7.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |